Weekly injections for T2D 

A once-weekly 2mg injection of Novo Nordisk’s Ozempic semaglutide product Ozempic has been approved for use in America, following results of the SUSTAIN FORTE trial,

Read More »

Nemaura win for sugarBEAT CGM

Nemaura Medical, manufacturer of the sugarBEAT continuous glucose monitor sold in the UK through MySugarWatch, and the Miboko body worn glucose sensor, has just received

Read More »